Legal & General Group PLC Immuno Gen, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$12.46 - $29.95 $258,557 - $621,492	20,751 Added 9.67%	235,326 $6.98 Million
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $28,546 - $40,256	2,026 Added 0.95%	214,575 $3.41 Million
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $450,240 - $2.41 Million	120,064 Added 129.82%	212,549 $4.01 Million
Q1 2023 May 15, 2023	BUY	$3.67 - $4.92 $23,098 - $30,966	6,294 Added 7.3%	92,485 $355,000
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $5,623 - $7,799	1,236 Added 1.45%	86,191 $427,000
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $28,954 - $41,815	6,463 Added 8.23%	84,955 $406,000
Q2 2022 Aug 22, 2022	SELL	$3.15 - $5.76 $4,372 - $7,994	-1,388 Reduced 1.74%	78,492 $353,000
Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $7,825 - $13,740	1,837 Added 2.35%	79,880 $380,000
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $11,556 - $18,247	2,433 Added 3.22%	78,043 $579,000
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $193,174 - $253,589	38,481 Added 103.64%	75,610 $428,000
Q2 2021 Aug 12, 2021	BUY	$5.79 - $8.6 $301 - $447	52 Added 0.14%	37,129 $245,000
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $25,246 - $40,898	3,884 Added 11.7%	37,077 $300,000
Q4 2020 Feb 12, 2021	SELL	$3.7 - $7.66 $13,460 - $27,867	-3,638 Reduced 9.88%	33,193 $214,000
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $26,523 - $37,594	-7,688 Reduced 17.27%	36,831 $133,000
Q2 2020 Aug 14, 2020	BUY	$3.32 - $5.34 $1,669 - $2,686	503 Added 1.14%	44,519 $205,000
Q1 2020 May 14, 2020	BUY	$2.12 - $6.8 $9,743 - $31,252	4,596 Added 11.66%	44,016 $150,000
Q4 2019 Feb 13, 2020	BUY	$2.25 - $5.8 $4,056 - $10,457	1,803 Added 4.79%	39,420 $201,000
Q3 2019 Nov 13, 2019	BUY	$2.22 - $3.39 $24,519 - $37,442	11,045 Added 41.57%	37,617 $91,000
Q4 2018 Feb 15, 2019	BUY	$3.94 - $9.7 $14,266 - $35,123	3,621 Added 15.78%	26,572 $128,000
Q3 2018 Nov 20, 2018	BUY	$8.6 - $11.26 $20,571 - $26,933	2,392 Added 11.63%	22,951 $218,000
Q2 2018 Aug 10, 2018	BUY	$9.52 - $12.15 $13,090 - $16,706	1,375 Added 7.17%	20,559 $200,000
Q1 2018 May 17, 2018	SELL	$6.7 - $12.95 $35,342 - $68,311	-5,275 Reduced 21.57%	19,184 $202,000
Q4 2017 Feb 13, 2018	BUY	$5.07 - $7.92 $124,007 - $193,715	24,459	24,459 $159,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account